Merck launches electronic growth hormone injection device |
|
|
|
Published
:
Tue, 30 Jan 2007 10:03
|
FRANKFURT (AFX) - Merck KGaA's Merck Serono business announced the launch of electronic growth hormone injection device easypod for administering the company's hormone deficiency therapy Saizen (somatropin).'This is a significant advance in our patient drug device portfolio that will support our efforts to improve patient treatment and will distinguish us from existing injection devices,' said head of the company's endocrinology therapeutic area Hans Christian Rohde.Merck acquired Swiss biotech company Serono SA for 10.6 bln eur in 2006.krysia.diver@afxnews.comkd/jrCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2374.41 |
-16.87 (
-0.71 %)
|
| SYMBOL (
2010-03-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
12:35pm )
|
|
2650.00 |
+52.00 (
2.00 %)
|
|
WHITBREAD
(
12:35pm )
|
|
1540.00 |
+21.00 (
1.37 %)
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Merck KGaA says 6.2 mln new shares placed at 87.00 eur/shr UPDATE 